Description

Tukanic 150mg Tablet (Tucatinib) Uses, Dosage, Side Effects & Price in Pakistan

Tukanic 150mg Tablet (Tucatinib) is an oral targeted cancer medicine containing tucatinib 150mg as its active ingredient. Tucatinib belongs to a group of medicines called tyrosine kinase inhibitors (TKIs) and works by blocking HER2 signals that can help certain cancer cells grow.

Tucatinib is used as part of combination cancer treatment. Official European information states that tucatinib is used with trastuzumab and capecitabine for adults with HER2-positive locally advanced or metastatic breast cancer who have previously received at least two anti-HER2 treatment regimens.

Tukanic 150mg is a prescription medicine and should only be used according to the treatment plan provided by an oncologist.

What Is Tukanic 150mg Tablet (Tucatinib)?

Tukanic 150mg Tablet contains tucatinib, a targeted anticancer medicine.

Tucatinib is a tyrosine kinase inhibitor that specifically targets the HER2 protein. HER2 can send signals that encourage certain cancer cells to grow and divide. By blocking HER2 signaling, tucatinib can help slow the growth and spread of HER2-positive cancer cells.

The 150mg strength is an oral tablet formulation of tucatinib. Depending on the treatment regimen, more than one tablet may be required to reach the prescribed daily dose.

The exact indication, strength, pack size and manufacturer information should always be checked against the packaging and official product information for the particular Tukanic product supplied in Pakistan.

Tukanic 150mg Tablet Uses

Tucatinib is mainly used as part of combination treatment for certain HER2-positive cancers.

HER2-Positive Breast Cancer

Official EMA information states that tucatinib is used with trastuzumab and capecitabine to treat adults with HER2-positive locally advanced or metastatic breast cancer who have previously received at least two anti-HER2 treatment regimens.

The U.S. FDA indication also covers adults with advanced unresectable or metastatic HER2-positive breast cancer, including patients with brain metastases, in combination with trastuzumab and capecitabine after prior anti-HER2 treatment.

HER2-Positive Colorectal Cancer

In the United States, tucatinib is also approved in combination with trastuzumab for certain adults with RAS wild-type, HER2-positive unresectable or metastatic colorectal cancer that has progressed after specified chemotherapy.

Because cancer-medicine approvals can differ between countries, patients should follow the indication provided by their oncologist and the local product information.

How Does Tucatinib Work?

Tucatinib works by targeting the HER2 protein found on certain cancer cells.

HER2 can act like a signal that tells cancer cells to grow and divide. Tucatinib blocks the activity of HER2, which can reduce these growth signals. This may slow the growth of certain HER2-positive cancer cells.

Tucatinib is therefore considered a targeted therapy, rather than a traditional chemotherapy medicine.

It is normally used together with other cancer medicines because combination treatment is an important part of its approved uses.

Tukanic 150mg Tablet Dosage

The recommended tucatinib dose in the official EMA product information is 300mg twice daily, taken in combination with trastuzumab and capecitabine for its listed breast cancer indication.

The 150mg tablet strength means that the prescribed 300mg dose may correspond to two 150mg tablets per dose, but patients should follow the exact instructions given by their oncologist.

The dose may need to be changed or treatment temporarily interrupted because of side effects, liver problems or interactions with other medicines.

Do not change the Tukanic dosage yourself. Cancer treatment should be supervised by an oncologist who can consider the patient’s cancer type, previous treatments, liver function, other medicines and overall health.

How to Take Tukanic 150mg Tablet

Tucatinib is taken by mouth.

According to official product information:

• Take Tukanic exactly as prescribed.
• It can be taken with or without food.
• Take doses at approximately the same times each day.
• Swallow the tablets according to the product instructions.
• Do not take an extra dose to make up for a missed dose unless your healthcare professional tells you to do so.

Tucatinib is generally used as part of a combination regimen with other cancer medicines. Patients should not start, stop or change any part of their cancer treatment without speaking to their oncology team.

Tukanic 150mg Tablet Side Effects

Like other cancer medicines, Tukanic may cause side effects. The type and severity can vary from person to person.

Possible side effects associated with tucatinib include:

• Diarrhea
• Nausea
• Vomiting
• Rash
• Increased liver enzymes
• Increased bilirubin
• Tiredness or weakness
• Mouth-related symptoms
• Headache

Some patients may experience more serious reactions, particularly involving the liver. Official product information recommends monitoring liver function during treatment.

Liver Problems

Tucatinib can cause changes in liver function tests and, in some cases, more serious liver injury.

Contact your healthcare professional if you develop symptoms such as unusual tiredness, yellowing of the skin or eyes, dark urine, loss of appetite or pain in the upper-right area of the abdomen.

Doctors may perform blood tests to monitor liver function during treatment.

Severe Diarrhea

Diarrhea is an important possible side effect of tucatinib. If diarrhea is severe or persistent, contact your doctor because treatment or supportive medicines may need to be adjusted.

Do not attempt to manage severe symptoms without medical advice.

Tukanic 150mg Precautions and Warnings

Before starting Tukanic, tell your doctor about your medical history and all medicines you currently use.

Important precautions include:

• Liver problems: Liver function should be monitored during treatment.
• Pregnancy: Tucatinib may cause harm to an unborn baby.
• Breastfeeding: Breastfeeding is generally not recommended during treatment.
• Drug interactions: Tucatinib can interact with medicines that affect CYP3A enzymes and certain transport proteins.
• Diarrhea: Persistent or severe diarrhea should be reported.
• Other cancer medicines: Tucatinib is normally prescribed as part of a specific combination treatment.

Your oncologist may order regular blood tests during treatment to monitor liver function and other important parameters.

Tukanic 150mg Tablet Drug Interactions

Tucatinib can interact with medicines that affect how the body processes the drug.

Strong CYP3A inhibitors may increase tucatinib exposure, while CYP3A inducers may reduce its exposure. Tucatinib can also affect certain medicines transported by proteins such as P-gp and BCRP.

Because the interaction list can be clinically important, tell your doctor about:

• Prescription medicines
• Over-the-counter medicines
• Vitamins
• Herbal products
• Other cancer treatments

Do not start a new medicine or supplement during Tukanic treatment without first discussing it with your healthcare professional.

Tukanic 150mg Pregnancy and Breastfeeding

Tucatinib can potentially harm an unborn baby. Women who can become pregnant should discuss appropriate contraception with their healthcare provider before and during treatment.

If pregnancy occurs while taking Tukanic, contact your oncologist promptly.

Breastfeeding should generally be avoided during treatment with tucatinib and for the period specified by the prescribing information after treatment ends. Patients should follow their oncologist’s advice regarding when breastfeeding can safely resume.

Tukanic 150mg Tablet Storage

Store Tukanic according to the storage instructions printed on the product packaging and official prescribing information.

Keep the medicine:

• In its original packaging
• Away from excessive heat and moisture
• Out of reach of children

Do not use tablets after the expiry date printed on the package.

For an imported product, always check the actual pack for storage instructions because packaging and labeling can differ between markets.

Tukanic 150mg Tablet Manufacturer

The manufacturer of Tukanic 150mg Tablet should be verified from the actual product packaging and official product information for the specific brand available in Pakistan.

Do not assume that the manufacturer of Tukanic is the same as the manufacturer of the reference tucatinib product. For imported medicines, check the manufacturer, marketing authorization details, batch number and expiry date on the supplied pack.

Tukanic 150mg Tablet Price in Pakistan

The Tukanic 150mg Tablet Price in Pakistan may vary depending on the supplier, pack size, import status, availability and market conditions.

Specialty oncology medicines can have changing prices because of supply and import factors.

Before ordering, confirm:

• Current price
• Pack size
• Product strength
• Manufacturer
• Expiry date
• Availability

Customers can check Impo Medic for the latest Tukanic 150mg price and availability in Pakistan.

Buy Tukanic 150mg Tablet in Pakistan

If you want to Buy Tukanic 150mg Tablet in Pakistan, you can contact Impo Medic to check current availability, pricing and ordering information.

Tukanic contains tucatinib and is a prescription cancer medicine. It should only be used as part of a treatment plan prescribed by a qualified oncologist.

Before purchasing an imported oncology medicine, confirm the exact product name, strength, pack size, manufacturer and expiry date.

Do not start Tukanic treatment without a valid medical prescription and professional guidance.

Why Choose Impo Medic?

Impo Medic provides customers with support when looking for specialized medicines in Pakistan.

Customers can benefit from:

• Clear product information
• Convenient online ordering
• Current availability information
• Transparent pricing where available
• Support for imported medicines
• Customer assistance with product-related questions
• Responsible medicine-use guidance

Availability and prices may change, particularly for imported specialty medicines, so customers should confirm current information before placing an order.

FAQs About Tukanic 150mg Tablet (Tucatinib)

1. What is Tukanic 150mg Tablet used for?

Tukanic contains tucatinib, a targeted cancer medicine used in combination with other medicines for certain HER2-positive cancers. Its approved uses can differ by country. In the EU, it is used with trastuzumab and capecitabine for certain HER2-positive locally advanced or metastatic breast cancer.

2. What is the active ingredient in Tukanic 150mg?

The active ingredient is tucatinib, a tyrosine kinase inhibitor that targets HER2 signaling.

3. How is Tukanic 150mg taken?

Tucatinib is taken orally. The official EMA recommended dose for its listed breast cancer indication is 300mg twice daily, although the exact treatment plan should be determined by the oncologist.

4. What are the common side effects of Tukanic?

Possible side effects include diarrhea, nausea, vomiting, rash, tiredness and changes in liver function tests. Your doctor may monitor you regularly during treatment.

5. Can Tukanic be taken with other medicines?

Yes, but tucatinib has clinically important drug interactions. Tell your oncologist about every medicine, supplement and herbal product you use before starting treatment.

6. Is Tukanic 150mg available in Pakistan?

Availability can vary depending on suppliers and imported stock. Contact Impo Medic to check current availability.

7. What is the price of Tukanic 150mg in Pakistan?

The price can vary according to pack size, supplier, import status and availability. Contact Impo Medic for the current price.

8. Does Tukanic require a prescription?

Yes. Tukanic is a prescription cancer medicine and should be used under the supervision of a qualified oncologist.